Yael Margolin is a director of POINT Biopharma Global Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
POINT Biopharma Global Inc.
27 Dec 23
4
POINT Biopharma Global Inc.
5 Jun 23
3/A
BiondVax Pharmaceuticals Ltd.
23 Jan 23
3
BiondVax Pharmaceuticals Ltd.
3 Jan 23
4
POINT Biopharma Global Inc.
23 Nov 22
4
POINT Biopharma Global Inc.
6 Jun 22
4
POINT Biopharma Global Inc.
8 Jul 21
3
POINT Biopharma Global Inc.
30 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Dec 23 | PNT POINT Biopharma Global | Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,710 | 0.00 | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.12 | 44,749 | 408.11 k | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.31 | 25,614 | 212.85 k | 0 |
27 Dec 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.47 | 25,000 | 211.75 k | 0 |
1 Jun 23 | PNT POINT Biopharma Global | Stock Option Common Stock | Grant | Acquire A | No | No | 9.12 | 44,749 | 408.11 k | 44,749 |